Literature DB >> 23979445

[Invasion patterns and metastasis of urothelial carcinoma. A challenge for translational research].

C Bolenz1, T Martini, M S Michel.   

Abstract

Local invasion of cancer cells occurs early during the progression of urothelial carcinoma. Micrometastatic disease and the presence of nodal metastases are major causes of cancer-specific mortality following radical surgery. Only surrogate markers for aggressive and micrometastatic disease have been identified. The metastatic cascade is complex, including multiple steps from initial invasion to colonization and proliferation at distant sites. The initial mechanisms of cancer cell dissemination in urothelial carcinoma are poorly understood. Various proteases, chemokines and growth factors are involved in this process and alterations of the lymphatic system may promote systemic spread. There is a high demand for therapeutic targeting of the metastatic process. Functional preclinical studies in representative models are therefore required to better elucidate the multiple steps of progression. We review the current knowledge on factors associated with metastasis in urothelial carcinoma. Preclinical approaches to identify key player molecules for invasion and to develop new therapeutic strategies are discussed.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23979445     DOI: 10.1007/s00120-013-3309-z

Source DB:  PubMed          Journal:  Urologe A        ISSN: 0340-2592            Impact factor:   0.639


  27 in total

Review 1.  Molecular biomarkers for urothelial carcinoma of the bladder: challenges in clinical use.

Authors:  Christian Bolenz; Yair Lotan
Journal:  Nat Clin Pract Urol       Date:  2008-12

Review 2.  Epithelial-mesenchymal transitions in development and disease.

Authors:  Jean Paul Thiery; Hervé Acloque; Ruby Y J Huang; M Angela Nieto
Journal:  Cell       Date:  2009-11-25       Impact factor: 41.582

3.  Association of angiogenesis related markers with bladder cancer outcomes and other molecular markers.

Authors:  Shahrokh F Shariat; Ramy F Youssef; Amit Gupta; Daher C Chade; Pierre I Karakiewicz; Hendrik Isbarn; Claudio Jeldres; Arthur I Sagalowsky; Raheela Ashfaq; Yair Lotan
Journal:  J Urol       Date:  2010-03-17       Impact factor: 7.450

Review 4.  Critical determinants of metastasis.

Authors:  Isaiah J Fidler
Journal:  Semin Cancer Biol       Date:  2002-04       Impact factor: 15.707

Review 5.  Lymphangiogenesis and tumor metastasis.

Authors:  Riccardo E Nisato; Jean-Christophe Tille; Michael S Pepper
Journal:  Thromb Haemost       Date:  2003-10       Impact factor: 5.249

6.  Lymphangiogenesis occurs in upper tract urothelial carcinoma and correlates with lymphatic tumour dissemination and poor prognosis.

Authors:  Christian Bolenz; Mario I Fernández; Lutz Trojan; Katja Hoffmann; Edwin Herrmann; Annette Steidler; Christel Weiss; Philipp Ströbel; Peter Alken; Maurice Stephan Michel
Journal:  BJU Int       Date:  2008-10-17       Impact factor: 5.588

7.  Assessing the invasive potential of bladder cancer: development and validation of a new preclinical assay.

Authors:  Christian Bolenz; Christian Gorzelanny; Daniel Knauf; Tanja Keil; Annette Steidler; Natalia Halter; Thomas Martini; Stefan W Schneider
Journal:  J Urol       Date:  2012-10-11       Impact factor: 7.450

8.  Prognostic implications of lymphangiogenesis in muscle-invasive transitional cell carcinoma of the bladder.

Authors:  Mario I Fernández; Christian Bolenz; Lutz Trojan; Annette Steidler; Christel Weiss; Peter Alken; Rainer Grobholz; Maurice Stephan Michel
Journal:  Eur Urol       Date:  2007-08-24       Impact factor: 20.096

9.  The electrical resistance breakdown assay determines the role of proteinases in tumor cell invasion.

Authors:  Thomas Ludwig; Rainer Ossig; Susanne Graessel; Marianne Wilhelmi; Hans Oberleithner; Stefan W Schneider
Journal:  Am J Physiol Renal Physiol       Date:  2002-08

10.  [New markers for pharmacological targeting in bladder cancer with lymph node metastasis].

Authors:  E Herrmann; E Eltze; T Köpke; C Bolenz; S Bierer; J Neumann; L Hertle; C Wülfing
Journal:  Aktuelle Urol       Date:  2007-09       Impact factor: 0.658

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.